BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 16109445)

  • 1. Human natural killer cells: Molecular mechanisms controlling NK cell activation and tumor cell lysis.
    Moretta L; Bottino C; Pende D; Vitale M; Mingari MC; Moretta A
    Immunol Lett; 2005 Aug; 100(1):7-13. PubMed ID: 16109445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different checkpoints in human NK-cell activation.
    Moretta L; Bottino C; Pende D; Vitale M; Mingari MC; Moretta A
    Trends Immunol; 2004 Dec; 25(12):670-6. PubMed ID: 15530838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple natural killer cell-activating signals are inhibited by major histocompatibility complex class I expression in target cells.
    Correa I; Corral L; Raulet DH
    Eur J Immunol; 1994 Jun; 24(6):1323-31. PubMed ID: 8206092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual effects of cytokines in regulation of MHC-unrestricted cell mediated cytotoxicity.
    Reiter Z
    Crit Rev Immunol; 1993; 13(1):1-34. PubMed ID: 8466640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection against natural killer cells by interferon-gamma treatment of K562 cells cannot be explained by augmented major histocompatibility complex class I expression.
    Nishimura M; Mitsunaga S; Akaza T; Mitomi Y; Tadokoro K; Juji T
    Immunology; 1994 Sep; 83(1):75-80. PubMed ID: 7821970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surface NK receptors and their ligands on tumor cells.
    Moretta L; Bottino C; Pende D; Castriconi R; Mingari MC; Moretta A
    Semin Immunol; 2006 Jun; 18(3):151-8. PubMed ID: 16730454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MHC class I expression on tumor targets inhibits natural killer cell-mediated cytotoxicity without interfering with target recognition.
    Kaufman DS; Schoon RA; Leibson PJ
    J Immunol; 1993 Feb; 150(4):1429-36. PubMed ID: 8432986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relation of natural killer cell line NK-92-mediated cytolysis (NK-92-lysis) with the surface markers of major histocompatibility complex class I antigens, adhesion molecules, and Fas of target cells.
    Komatsu F; Kajiwara M
    Oncol Res; 1998; 10(10):483-9. PubMed ID: 10338151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissecting natural killer cell activation pathways through analysis of genetic mutations in human and mouse.
    Tassi I; Klesney-Tait J; Colonna M
    Immunol Rev; 2006 Dec; 214():92-105. PubMed ID: 17100878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NKG2D and natural cytotoxicity receptors are involved in natural killer cell interaction with self-antigen presenting cells and stromal cells.
    Poggi A; Prevosto C; Zancolli M; Canevali P; Musso A; Zocchi MR
    Ann N Y Acad Sci; 2007 Aug; 1109():47-57. PubMed ID: 17785290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unravelling natural killer cell function: triggering and inhibitory human NK receptors.
    Moretta L; Moretta A
    EMBO J; 2004 Jan; 23(2):255-9. PubMed ID: 14685277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular ligands of activating NK receptors.
    Bottino C; Castriconi R; Moretta L; Moretta A
    Trends Immunol; 2005 Apr; 26(4):221-6. PubMed ID: 15797513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surface receptors delivering opposite signals regulate the function of human NK cells.
    Moretta A; Biassoni R; Bottino C; Moretta L
    Semin Immunol; 2000 Apr; 12(2):129-38. PubMed ID: 10764621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rat NKp46 activates natural killer cell cytotoxicity and is associated with FcepsilonRIgamma and CD3zeta.
    Westgaard IH; Berg SF; Vaage JT; Wang LL; Yokoyama WM; Dissen E; Fossum S
    J Leukoc Biol; 2004 Dec; 76(6):1200-6. PubMed ID: 15356098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutual interference of HIV and natural killer cell-mediated immune response.
    Jacobs R; Heiken H; Schmidt RE
    Mol Immunol; 2005 Feb; 42(2):239-49. PubMed ID: 15488611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor cell recognition by natural killer cells.
    Long EO
    Semin Cancer Biol; 2002 Feb; 12(1):57-61. PubMed ID: 11926413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-linking of MHC class I molecules on human NK cells inhibits NK cell function, segregates MHC I from the NK cell synapse, and induces intracellular phosphotyrosines.
    Rubio G; Férez X; Sánchez-Campillo M; Gálvez J; Martí S; Verdú R; Hernández-Caselles T; García-Peñarrubia P
    J Leukoc Biol; 2004 Jul; 76(1):116-24. PubMed ID: 15123774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural killer lymphocytes: "null cells" no more.
    Moretta A; Bottino C; Sivori S; Marcenaro E; Castriconi R; Della Chiesa M; Carlomagno S; Augugliaro R; Nanni M; Vitale M; Millo R
    Ital J Anat Embryol; 2001; 106(4):335-42. PubMed ID: 12003235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of human T-lymphotropic virus type-1 (HTLV-1)-infected cell line MT-2, which is not killed by a natural killer cell line NK-92 but is killed by lymphokine-activated killer cells.
    Komatsu F; Yoshida S
    Oncol Res; 1999; 11(5):213-8. PubMed ID: 10608615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human NK cell education by inhibitory receptors for MHC class I.
    Anfossi N; André P; Guia S; Falk CS; Roetynck S; Stewart CA; Breso V; Frassati C; Reviron D; Middleton D; Romagné F; Ugolini S; Vivier E
    Immunity; 2006 Aug; 25(2):331-42. PubMed ID: 16901727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.